Staar Surgical Shines In May; Stock Gains 28% On Restructuring Potential
This article was originally published in The Gray Sheet
Executive Summary
Investors seeing upside earnings potential in Staar Surgical's May restructuring effort, management changes and new product milestones helped make the ophthalmic device firm's stock a star performer on Wall Street during the month. The issue jumped 28.2% to 13-5/8 in May, a 3-point gain.